|
(P1786) |
Welche Aussagekraft haben kardiale und inflammatorische Biomarker für den Schweregrad einer stabilen koronaren Herzerkrankung und das Langzeitüberleben bei Frauen und Männern? |
| |
|
J. Netto, R. Burkhardt, U. Ceglarek, S. Henger, G. C. Schuler, J. Thiery, M. Scholz, A. Teren (Leipzig) |
|
(P1787) |
Comparison of NCDR-, GRACE- and CRUSADE-Scores for Mortality and Bleeding Risk Prediction in Acute Coronary Syndrome in a German Population |
| |
|
G. Wolff, J. Quade, L. Kosejian, S. Bader, Y. Lin, M. Brockmeyer, A. Karathanos, Y. Heinen, M. Kelm, V. Schulze (Düsseldorf) |
|
(P1788) |
Variants of PEAR1 are associated with Outcome in Cardiovascular Patients |
| |
|
F. Stimpfle, M. Bauer, D. Rath, E. Schaeffeler, S. Winter, M. Schwab, M. Gawaz, T. Geisler (Tübingen, Stuttgart) |
|
(P1789) |
Apolipoprotein C-III concentrations in chylomicron-free serum predict cardiovascular outcomes in patients with coronary artery disease |
| |
|
C. Werner, T. Stojakovic, T. Speer, S. Zewinger, W. März, H. Scharnagl, M. Böhm, U. Laufs (Homburg/Saar, Mannheim, Leipzig; Graz, AT) |
|
(P1790) |
Quality of life at long-term follow-up in patients with coronary vasomotor disorders and unobstructed coronary arteries |
| |
|
P. Ong, J. Gardezy, S. Hill, H. Mahrholdt, T. Schäufele, A. Athanasiadis, U. Sechtem (Stuttgart) |
|
(P1791) |
Long-term prognosis of patients with coronary vasomotor disorders and unobstructed coronary arteries |
| |
|
P. Ong, J. Gardezy, S. Hill, H. Mahrholdt, T. Schäufele, A. Athanasiadis, U. Sechtem (Stuttgart) |